Latham & Watkins represented Amgen in the offerings.Amgen Inc., one of the world’s leading biotechnology companies, priced on February 17, 2022, a senior unsecured notes offerings…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
